Funeng Jiang

2.2k citations

65 papers · 1.5k indexed · h-index 25

Impact in

Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation

Papers in ⓘ

Cancer Research 17
- MicroRNA in disease regulation 7
- Cancer, Hypoxia, and Metabolism 7
- Cancer, Lipids, and Metabolism 5
Molecular Biology 44
- Circular RNAs in diseases 7
- Ubiquitin and proteasome pathways 7
- RNA Research and Splicing 6
- Epigenetics and DNA Methylation 6

Co-authors: Weide Zhong (49 shared papers)Huichan He (24 shared papers)Zhaodong Han (21 shared papers)Yuxiang Liang (18 shared papers)Qi-Shan Dai (10 shared papers)Jianguo Zhu (14 shared papers)Yanqiong Zhang (7 shared papers)Yongding Wu (12 shared papers)
Journals: OncoTargets and Therapy (3 papers)Pathology & Oncology Research (3 papers)International Journal of Cancer (2 papers)Medical Oncology (2 papers)Current Cancer Drug Targets (2 papers)
Partner nations: China United States Macao

In The Last Decade

Funeng Jiang

61 papers receiving 1.5k citations

Peers

Countries citing papers authored by Funeng Jiang

Since Specialization

Citations

This map shows the geographic impact of Funeng Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Funeng Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Funeng Jiang more than expected).

Fields of papers citing papers by Funeng Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Funeng Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Funeng Jiang. The network helps show where Funeng Jiang may publish in the future.

Co-authors

The 25 scholars most cited alongside Funeng Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Funeng Jiang Line = papers co-authored together Funeng Jiang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer Clinical Cancer Research ·Chao Cai, Qing-Biao Chen, Zhaodong Han, Yanqiong Zhang, Huichan He, Jia-Hong Chen, Yanru Chen, Sheng-Bang Yang, Yongding Wu, Yanru Zeng, Guoqiang Qin, Yuxiang Liang, Qi-Shan Dai, Funeng Jiang, Shulin Wu, Guohua Zeng, Weide Zhong, Chin‐Lee Wu	2015	103
2	MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1 International Journal of Cancer ·Zhuoyuan Lin, Yaqiang Huang, Yanqiong Zhang, Zhaodong Han, Huichan He, Xiaohui Ling, Xin Fu, Qi-Shan Dai, Chao Cai, Jiahong Chen, Yuxiang Liang, Funeng Jiang, Weide Zhong, Fen Wang, Chin‐Lee Wu	2013	89
3	Dysregulated microRNA-224/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancer Human Pathology ·Yueping Wan, Zhao-chang Zeng, Ming Xi, Wan Song, Wei Hua, Yuanling Liu, Yulin Zhou, Hongwei Luo, Funeng Jiang, Weide Zhong	2014	63
4	GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate Cancer Research ·Jianjiang Xie, Jian‐Heng Ye, Zhiduan Cai, Yong Luo, Xuejin Zhu, Yulin Deng, Yuanfa Feng, Yingke Liang, Ren Liu, Zhaodong Han, Yuxiang Liang, Yu Zheng, Rujun Mo, Yangjia Zhuo, Yongding Wu, Funeng Jiang, Jianguo Zhu, Chin‐Lee Wu, Weide Zhong	2020	51
5	Association Between Cd Exposure and Risk of Prostate Cancer Medicine ·Jukun Song, Dongbo Yuan, Haofu Rao, Tianfei Chen, Boshi Luan, Xiaoming Xu, Funeng Jiang, Weide Zhong, Jianguo Zhu	2016	50
6	E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer International Journal of Oncology ·Yuxiang Liang, Jianming Lü, Rujun Mo, Huichan He, Jian Xie, Funeng Jiang, Zhuoyuan Lin, Yanru Chen, Yongding Wu, Hongwei Luo, Zheng Luo, Weide Zhong	2016	47
7	Elevated levels of mitochondrion‐associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer Cancer ·Xianhan Jiang, Xun Li, Hai Huang, Funeng Jiang, Zhuoyuan Lin, Huichan He, Yanru Chen, Fei Yue, Jing Zou, Yongzhong He, Pan You, Wenwei Wang, Weiqing Yang, Haibo Zhao, Yiming Lai, Fen Wang, Weide Zhong, Leyuan Liu	2014	47
8	Expression of PD‐L1 in tumor‐associated nerves correlates with reduced CD8⁺ tumor‐associated lymphocytes and poor prognosis in prostate cancer International Journal of Cancer ·Rujun Mo, Zhaodong Han, Yingke Liang, Jian‐Heng Ye, Shulin Wu, Sharron X. Lin, Yanqiong Zhang, Shengda Song, Funeng Jiang, Weide Zhong, Chin‐Lee Wu	2018	44
9	Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients Molecular Carcinogenesis ·Xianhan Jiang, Weide Zhong, Hai Huang, Huichan He, Funeng Jiang, Yanru Chen, Fei Yue, Jing Zou, Xun Li, Yongzhong He, Pan You, Weiqiang Yang, Yiming Lai, Fen Wang, Leyuan Liu	2014	44
10	Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer Medical Oncology ·Yaqiang Huang, Zhaodong Han, Yuxiang Liang, Zhuoyuan Lin, Xiaohui Ling, Xin Fu, Chao Cai, Xue‐cheng Bi, Qi-Shan Dai, Jia-Hong Chen, Huichan He, Yanru Chen, Funeng Jiang, Weide Zhong	2013	43
11	Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy Autophagy ·Zhaochen Ma, Wenjia Chen, Yudong Liu, Lingxiang Yu, Xia Mao, Xiaodong Guo, Funeng Jiang, Qiuyan Guo, Na Lin, Yanqiong Zhang	2023	43
12	Expression of Hedgehog Pathway Components is Associated with Bladder Cancer Progression and Clinical Outcome Pathology & Oncology Research ·Huichan He, Jiahong Chen, Xi-bin Chen, Guo-qiang Qin, Chao Cai, Yuxiang Liang, Zhaodong Han, Qi-Shan Dai, Yanru Chen, Guohua Zeng, Jianguo Zhu, Funeng Jiang, Weide Zhong	2011	42
13	Expression of SOCSs in human prostate cancer and their association in prognosis Molecular and Cellular Biochemistry ·Jianguo Zhu, Qi-Shan Dai, Zhaodong Han, Huichan He, Rujun Mo, Guo Chen, Yanfei Chen, Yongding Wu, Sheng-Bang Yang, Funeng Jiang, Weihong Chen, Zhaolin Sun, Weide Zhong	2013	41
14	Metastatic prostate cancer‐associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6 The Prostate ·Xianhan Jiang, Yiqiao Huang, Xue Liang, Funeng Jiang, Yongzhong He, Tian Li, Guibin Xu, Haibo Zhao, Weiqing Yang, Ganggang Jiang, ZHENGMING SU, Lingke Jiang, Leyuan Liu	2018	41
15	CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer BioMed Research International ·Guo Chen, Yuxiang Liang, Jianguo Zhu, Xin Fu, Yanfei Chen, Rujun Mo, Liang Zhou, Hao Fu, Xue‐cheng Bi, Huichan He, Sheng-Bang Yang, Yongding Wu, Funeng Jiang, Weide Zhong	2014	41
16	Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer. PubMed ·Chao Cai, Jinyan Chen, Zhaodong Han, Huichan He, Jiahong Chen, Yanru Chen, Sheng-Bang Yang, Yongding Wu, Yanru Zeng, Jun Zou, Yuxiang Liang, Qi-Shan Dai, Funeng Jiang, Weide Zhong	2015	39
17	MicroRNA-335 Acts as a Candidate Tumor Suppressor in Prostate Cancer Pathology & Oncology Research ·Siwei Xiong, Tianxin Lin, Kewei Xu, Wen Dong, Xiaohui Ling, Funeng Jiang, Guo Chen, Weide Zhong, Jian Huang	2013	36
18	BACH1 promotes the progression of human colorectal cancer through BACH1/CXCR4 pathway Biochemical and Biophysical Research Communications ·Guodong Zhu, Feng Liu, Shi Ouyang, Rui Zhou, Funeng Jiang, Bei Zhang, Wangjun Liao	2018	35
19	MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer Molecular Biology Reports ·Xiaohui Ling, Zhaodong Han, Dan Xia, Huichan He, Funeng Jiang, Zhuoyuan Lin, Xin Fu, Ye-han Deng, Qi-Shan Dai, Chao Cai, Jiahong Chen, Yuxiang Liang, Weide Zhong, Chin‐Lee Wu	2014	33
20	Overexpression of TPX2 is associated with progression and prognosis of prostate cancer Oncology Letters ·Jun Zou, Ruiyan Huang, Funeng Jiang, Dexiong Chen, Cong Wang, Zhaodong Han, Yuxiang Liang, Weide Zhong	2018	31

About Funeng Jiang

Funeng Jiang is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Immunology and Allergy, having authored 65 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (13 papers), Circular RNAs in diseases (7 papers), MicroRNA in disease regulation (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Ubiquitin and proteasome pathways (7 papers), RNA Research and Splicing (6 papers), Epigenetics and DNA Methylation (6 papers) and Cancer, Lipids, and Metabolism (5 papers). The work is most often cited by research in Cancer Research (564 citations), Molecular Biology (954 citations), Oncology (280 citations), Pulmonary and Respiratory Medicine (330 citations) and Cell Biology (117 citations). Funeng Jiang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Weide Zhong, Huichan He, Zhaodong Han, Yuxiang Liang, Qi-Shan Dai, Jianguo Zhu, Yanqiong Zhang, Yongding Wu, Chin‐Lee Wu and Sheng-Bang Yang. Their work appears in journals such as OncoTargets and Therapy, Pathology & Oncology Research, International Journal of Cancer, Medical Oncology and Current Cancer Drug Targets.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiao TanBreakdown of academic impact, for papers by Xiangjin ZhengBreakdown of academic impact, for papers by Wanming HeBreakdown of academic impact, for papers by Zhiwei HeBreakdown of academic impact, for papers by Zhaodong HanBreakdown of academic impact, for papers by Lingao JuBreakdown of academic impact, for papers by Yi ShenBreakdown of academic impact, for papers by Xian Lin